Related people
Dr. Stefanie Greifeneder
Stefanie is an expert in all regulatory, commercial and contractual matters in the pharmaceutical, medical device and biotech sector as well as in compliance-relevant topics in this area. She advises on the drafting and negotiation of complex and cross-border licensing agreements (out-licensing and in-licensing), research and development collaborations, manufacturing and distribution agreements as well as clinical trial agreements and with CROs.
In M&A and private equity transactions in the life sciences sector, she advises on all regulatory and contractual issues.
Show full CV
Hide full CV
More
Show less
More
Show less
Career
| Since 2023 | Partner, Taylor Wessing |
| 2013 - 2023 | Partner, Fieldfisher, Munich |
| 2012 - 2013 | Counsel, Salans LLP, Frankfurt am Main |
| 2010 - 2012 | Senior Associate, Raupach, Frankfurt am Main |
| 2004 - 2009 | Associate, Ashurst LLP, Munich |
Education
| 2004 - 2008 | Doctoral degree, dissertation on „Health and Nutrition Claims on Foods“ |
| 2004 | Admission as a lawyer |
| 2004 | Second State Examination, Munich |
| 2002 | First State Examination, Munich |
| 1997 - 2002 | Legal Studies at Ludwig-Maximilians-University Munich |
Additional languages
| English |
Latest news & insights
Life sciences & healthcare
Click here to find out more
R&D Collaborations | Coffee Break Life Sciences Start-ups #4
18 April 2024
In-depth analysis
Patents & innovation
Click here to find out more
Important for start-ups: Confidentiality Agreements and Material Transfer Agreements (MTAs)
27 March 2024
Briefing
Corporate/M&A & capital markets
Click here to find out more
Bertelsmann Investments acquires pharma tech company EXTEDO with Taylor Wessing
27 February 2024
by multiple authors
Life sciences & healthcare
Click here to find out more
Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1
30 January 2024
In-depth analysis